TickerFacts.

Company research / CRVO

CervoMed Inc. (CRVO)

Build a valuation ↗↓ Download CSV

CIK 0001053691 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, CervoMed Inc. reported revenue of $4.01M. Revenue fell 58.9% from the prior annual period.

Key ratios (year ended 2025-12-31)

-706.2%
Operating margin
-673.1%
Net margin
-148.0%
Return on year-end equity
-58.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-08-10

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312023-08-162022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue$4.01M$9.74M$7.14M—$0—————
Operating Income-$28.29M-$18.23M-$7.81M—-$3.48M-$24.68M-$15.97M-$11.55M-$18.96M-$11.35M
Net Income-$26.97M-$16.29M-$2.17M—-$5.80M-$24.10M-$14.19M-$11.80M-$18.37M-$1.36M
EPS (Diluted)————$2038891.00$1946859.00$53831973.00$6706509.00$3242301.00$-29.11
Total Assets$22.88M$43.08M$9.97M—$4.16M$37.84M$27.73M$24.11M$18.20M$26.15M
Total Liabilities$4.66M$3.88M$2.60M—$13.16M$2.93M$2.92M$3.98M$2.59M$4.92M
Shareholders' Equity$18.22M$39.20M$7.38M—-$33.29M$34.91M$24.81M$20.13M$15.61M$21.23M
Cash & Equivalents$8.24M$9.00M$7.79M—$4.09M$37.31M$18.52M$14.18M$7.99M$8.90M
Operating Cash Flow-$23.45M-$16.53M-$7.45M—-$2.57M-$14.50M-$13.55M-$9.86M-$10.77M-$12.33M
Capital Expenditures—————————$447.8K
Shares Outstanding9.25M8.70M5.67M5.67M518.1K2.04M64.02M33.48M3.38M968.0K
Weighted Average Diluted Shares————————3.24M848.1K
EPS (Basic)$-2.98$-2.02$-0.82—$-11.20$-12.38$-0.30$-1.76$-8.21$-3.16